IMVT
IMVT
NASDAQ · Biotechnology

Immunovant Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$39.95
+0.21 (+0.53%)
As of Aug 8, 1:23 AM ET ·
Analyst Consensus
Strong Buy
24
Analysts
High
Coverage
Buy 18 75%
Hold 6 25%
Sell 0 0%
Price Target
Analyst Price Target +52.5% upside
Low Target $43.15
Average Target $60.94
High Target $94.48
Current Price $39.95
Current
$39.95
Target
$60.94
$43.15 $60.94 avg $94.48
Scenario Analysis
Bear Case
$43.15
8.0%
Low target
Base Case
$60.94
+52.5%
Avg target
Bull Case
$94.48
+136.5%
High target
Risk/Reward
17.0x
Highly favorable
Price in Context
52-Week High
$41.23
-3.1% from high
52-Week Low
$14.32
+179.0% from low
50-Day SMA
$25.99
+53.7% vs SMA
200-Day SMA
$19.59
+103.9% vs SMA
RSI (14)
49.5
Neutral
Target vs 52W High
$60.94
+47.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 39 79% $257.58 +4.7%
AMGN
Amgen Inc
 Hold 43 49% $190.87 -53.6%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +172.3%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -11.6%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -90.2%
NTRA
Natera Inc
 Strong Buy 30 87% $142.91 -55.6%
RVMD
Revolution Medicines Inc
 Strong Buy 29 93% $114.11 -44.4%
BIIB
Biogen Inc
 Buy 44 64% $91.45 -56.0%